Ahara

At Ahara, we built our facility for expansion. But we currently have 5,000 sq meters of flowering greenhouse. On an annual basis, we can produce roughly 5,000 kgs of dried flowers. That’s enough production to supply partners in multiple countries, including countries outside of Europe, like Australia, which was the destination of our first commercial batches. In addition, we’re also building relationships in Germany and the UK. And we’ll be sending our first shipments there in early 2025. That’s the advantage of a large production capacity. We don’t rely on one partner or market. We have more flexibility! To learn more, send us an email at info@ahara.pt. #medical #cannabis #europe

The THC conversation is changing again. As patient access increases, patient demand is evolving. In 2018, when Ahara first broke ground, the market needed products. The market was new, and European demand outweighed supply. As supply increased, the market demanded higher THC. Now, as demand increases, the evolution of demand is changing again. And the price to patients has become more influential than ever. THC is no longer driving the market all on its own. That’s good for patients and producers. Overall, quality is what matters. Not THC. Do you agree? #cannabis #medicine #europe

Cannabis breeding has existed for decades. Combining desired genetic traits to create unique offerings. It sounds simple, but it’s difficult and time-consuming. That’s why we partner with the best in genetics. Breeders who provide us with the following: - Genetic-specific cultivation knowledge  - Genetic-specific historical data - Genetic-specific experience It’s the collaboration that makes the difference. The combination of creator and producer. Both with the same goal: Harvest the best flower possible. Follow us here, Ahara! #cannabis #medicine #europe

The holidays are approaching, and candles are everywhere. Why? We love the aromas (just like in our greenhouse). One aroma that’s filled the facility lately is citrusy. It’s a familiar smell that awakens the soul. Energizing, uplifting, and elevating. Where does it come from? Limonene! The dominant terpene in a few of our genetics.  For more information, email us at info@ahara.pt #medical #cannabis #europe

Welcome to Ahara’s greenhouse! Nestled in the picturesque landscapes of Portugal… Our cutting-edge cultivation and manufacturing facility embodies the pinnacle of agricultural innovation and pharmaceutical excellence. We're equipped with the latest cultivation technology, including: -Automated climate control systems - Advanced irrigation setups - Supplemental lighting - 24/7 Monitoring Which all provide Ahara with the flexibility to make adjustments. Adjustments that will help improve our environment. And improve our quality of production. To stay informed on our progress, follow us here at Ahara! #cannabis #medicine #europe

The plant-to-patient journey is complicated. That’s why we’re focused on building reliable supply chains. Supply chains with dedicated and knowledgeable teams on both sides. This is what guarantees the plants we produce get to patients. Instead of sitting in inventory, waiting to be packaged. (A typical situation where everyone loses) Including: Patients | Physicians | Pharmacies | Wholesalers | Producers At Ahara, we want all stakeholders to benefit. Complicated or not! For partnership opportunities, email us at info@ahara.pt #cannabis #medicine #europe

Terpenes aren’t required on a CoA. But when it comes to quality, they mean everything. To increase terpene production, we choose to grow in perlite. Why? Perlite provides multiple advantages… 1) Improved Root Oxengation 2) Temperature Regulation 3) Enhanced Drainage Which all support terpene production. A clear criteria for high-quality. Even if not on the CoA. For more information, email us at info@ahara.pt #medical #cannabis #europe

Pillar 2 of CanG is uncertain. But what about the patients outside of Germany? The ones who remain without access to safe, reliable medical cannabis. Shouldn’t they be more of a significant concern than Pillar 2? Concerns such as: How can patient access across Europe improve? How do we get regulators to communicate? How can we create an EU standard?  At Ahara, patients (all of them) are always the priority. Regardless of what’s going on in Germany. Follow us here at Ahara! #cannabis #medicine #europe

It’s been a busy month at Ahara! We’ve had harvests and customer visits every week. Naturally, as operations ramp up, so do commercial conversations. And we’re committed to making time for important things like: - Face-to-face conversations - Tours around the facility - Lunch in the village But we wouldn’t be able to do it without our team. The plants need constant attention, regardless of who’s visiting. Ultimately, it’s about what we DO, not what we SAY. Follow our journey here, Ahara! #europe #medical

Outdoor = Sun, Indoor = Lights Hybrid Dutch Greenhouse = Sun + Lights At Ahara, we’re harnessing the power of both man and nature. We utilize two lighting solutions (one natural and one not). The Sun Provides a cost-effective natural light solution we can rely on. Lights Provides supplemental lighting for days we can’t rely on the sun. The result: We create a unique environment unlike any other. Which produces a highly demanded medical flower. With a superior level of desired qualities. Email us at info@ahara.pt #cannabis #medicine #europe